Tag Archives: Harvard

Big Pharma’s Scam: U.S. Drug companies rig medication studies

Mercola.com—New research has revealed just how misleading and questionable the results of medication studies cited in top medical journals actually are — adding to an already sizeable mountain of data on mainstream medical manipulation. Pharmaceutical and vaccine makers are continually found to be sponsoring the very institution performing the study on the effectiveness of their product.

Such is the case with a recent inquiry that examined the trustworthiness of top drug trials. Investigators from UCLA and Harvard recently analyzed the randomized drug trials from six prestigious journals, reaching a conclusion that brings into question the overall credibility of many top medication studies and those who perform them.

Pharma-Funded Psychiatrists Behind Bogus Child ‘Bi-Polar’ Epidemic- Disciplined for Conflicts of Interest

The primary promoters–inventors, one might say– of diagnosing children with “bipolar” disorder, who for over a decade, aggressively promoted the biopolar diagnosis and use of antipsychotics in children, were disciplined by Harvard University and its affiliated Massachusetts General Hospital.

An investigation, prompted by Sen. Charles Grassely, was conducted by Harvard University-affiliated Massachusetts General Hospital. It concluded (earlier this month) that psychiatrist Joseph Biederman and two of his proteges, Thomas Spencer and Timothy Wilens -each of who failed to disclose millions of dollars they had each received from the makers of antipsychotics, the drugs they promoted for the treatment of bipolar in children–had indeed violated the University’s/ and hospital’s conflict of interest reporting standards. The companies that paid them millions include: Eli Lilly, Johnson & Johnson, Pfizer, GlaxoSmithKline and Bristol-Myers Squibb.

Doctors draw payments from drug companies: Physicians say presentations they make are educational, but critics say the practice puts financial rewards ahead of patient care

Follow drug company money in Illinois, and it leads to the psychiatry department at Rush University Medical Center, a prominent headache clinic on the North Side of Chicago, a busy suburban urology practice and a psychiatric hospital accused of overmedicating kids.

In each of these settings, doctors are drawing an extra paycheck — worth tens of thousands of dollars a year or more — for speaking to other medical professionals about pharmaceutical products at company-sponsored, company-scripted events in Illinois and across the country.